Blackstone Said to Near $1.7 Billion Deal for Summit’s VaxCare

Feb. 21, 2025, 10:10 PM UTC

Blackstone Inc. is in advanced talks to acquire vaccine management company VaxCare Corp. for about $1.7 billion including debt, according to people familiar with the matter.

A deal for Summit Partners-backed VaxCare could be announced within weeks, said the people, who asked not to be identified because because the information is private. A final agreement hasn’t been reached and talks could still end without one, the people said.

Orlando-based VaxCare offers a platform for medical practices and health systems to manage inventory, billing and tracking for vaccines and contraceptive devices, according to its website.

Private equity firm Summit invested ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.